EdgeWater 3/2/2011 12:41:44 PM
News / Business

Drug Stocks Mostly Lower (PDLI, Mylan Inc., GENZ, MDT)

Drug Stocks Mostly Lower

PDL BioPharma Inc. (NASDAQ:PDLI) slid 0.27% to $5.53. The stock has a 52-week range of $4.66-$7.30.

The stock has average daily volume of 2.89 million shares. At current market price, the market capitalization of the company stands at $773.13 million.

Mylan Inc. (NASDAQ:MYL) lost 0.31% to $22.80. The stock has a 52-week range of $16.55-$24.17.

Mylan Inc. is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients (APIs).

Genzyme Corporation (NASDAQ:GENZ) added 0.07% to $75.50. The company announced that it has completed the sale of its pharmaceutical intermediates business to International Chemical Investors Group (ICIG). ICIG purchased substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion.

The stock has average daily volume of 3.14 million shares. At current market price, the market capitalization of the company stands at $19.55 billion.

Medtronic, Inc. (NYSE:MDT) is down 0.68% to $39.65. The stock opened at $40 and is trading within the range of $39.63-$40.15.

Article published by Wall Street Grand. Visit the Wall Street Grand Club today.


SAFE LINK

Disclaimer: For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html  

staffwallstreetgrand.com
www.wallstreetgrand.com